These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 37424186)
1. Structure based virtual screening and discovery of novel inhibitors against FabD protein of Sundararajan S; Karunakaran K; Muniyan R J Biomol Struct Dyn; 2024 Aug; 42(12):6280-6291. PubMed ID: 37424186 [TBL] [Abstract][Full Text] [Related]
3. Screening of Antitubercular Compound Library Identifies Inhibitors of Mur Enzymes in Eniyan K; Rani J; Ramachandran S; Bhat R; Khan IA; Bajpai U SLAS Discov; 2020 Jan; 25(1):70-78. PubMed ID: 31597510 [TBL] [Abstract][Full Text] [Related]
4. Identification of DprE1 inhibitors for tuberculosis through integrated in-silico approaches. Dash S; Rathi E; Kumar A; Chawla K; Kini SG Sci Rep; 2024 May; 14(1):11315. PubMed ID: 38760437 [TBL] [Abstract][Full Text] [Related]
5. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship. Tomioka H Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755 [TBL] [Abstract][Full Text] [Related]
6. Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach. Uddin R; Zahra NU; Azam SS Comput Biol Chem; 2019 Apr; 79():91-102. PubMed ID: 30743161 [TBL] [Abstract][Full Text] [Related]
13. A Preclinical Candidate Targeting Mycobacterium tuberculosis KasA. Inoyama D; Awasthi D; Capodagli GC; Tsotetsi K; Sukheja P; Zimmerman M; Li SG; Jadhav R; Russo R; Wang X; Grady C; Richmann T; Shrestha R; Li L; Ahn YM; Ho Liang HP; Mina M; Park S; Perlin DS; Connell N; Dartois V; Alland D; Neiditch MB; Kumar P; Freundlich JS Cell Chem Biol; 2020 May; 27(5):560-570.e10. PubMed ID: 32197094 [TBL] [Abstract][Full Text] [Related]
14. Drug targeted virtual screening and molecular dynamics of LipU protein of Mycobacterium tuberculosis and Mycobacterium leprae. Kaur G; Pandey B; Kumar A; Garewal N; Grover A; Kaur J J Biomol Struct Dyn; 2019 Mar; 37(5):1254-1269. PubMed ID: 29557724 [TBL] [Abstract][Full Text] [Related]
15. Discovery of novel and potent InhA direct inhibitors by ensemble docking-based virtual screening and biological assays. Zhang Q; Han J; Zhu Y; Yu F; Hu X; Tong HHY; Liu H J Comput Aided Mol Des; 2023 Dec; 37(12):695-706. PubMed ID: 37642861 [TBL] [Abstract][Full Text] [Related]
16. X-ray crystal structure of Mycobacterium tuberculosis beta-ketoacyl acyl carrier protein synthase II (mtKasB). Sridharan S; Wang L; Brown AK; Dover LG; Kremer L; Besra GS; Sacchettini JC J Mol Biol; 2007 Feb; 366(2):469-80. PubMed ID: 17174327 [TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors. Doğan ŞD; Gündüz MG; Doğan H; Krishna VS; Lherbet C; Sriram D Eur J Med Chem; 2020 Aug; 199():112402. PubMed ID: 32417538 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of potent inhibitors of β-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents. Liu Y; Zhong W; Li RJ; Li S Molecules; 2012 Apr; 17(5):4770-81. PubMed ID: 22534662 [TBL] [Abstract][Full Text] [Related]
20. Virtual screening to identify novel potential inhibitors for Glutamine synthetase of Kumari M; Subbarao N J Biomol Struct Dyn; 2020 Oct; 38(17):5062-5080. PubMed ID: 31755360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]